Clinical Trial Update: Study of Therapeutic Efficacy of Anti-CD19 CAR-T Cell Therapy in Patients With MDR-SRNS [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating anti-CD19 CAR-T cell therapy for multidrug-resistant steroid-resistant nephrotic syndrome is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephrotic Syndrome
• Steroid-resistant Nephrotic Syndrome

Drugs mentioned

• Anti-CD19 CAR-T cell therapy (CD19-targeted chimeric antigen receptor T cells)

Snippet

Sponsor: The Children's Hospital of Zhejiang University School of Medicine | Conditions: Multi-Drug Resistant Nephrotic Syndrome, CAR-T Cell Therapy | Phase 1 | Status: RECRUITING